Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHANDO Group (formerly Jala Group) is a leading Chinese technology-driven beauty and biotechnology company headquartered in Shanghai. Founded in 2001, the company integrates advanced life sciences research—including microbial fermentation, epigenetics, and 3D bioprinting—to develop proprietary skincare and personal care products. Its R&D strategy emphasizes a 'natural high-tech' philosophy, focusing on ingredients sourced from the Himalayan region, such as the proprietary polar yeast HiMurchaSin®. CHANDO is a pioneer in space-based bioscience, collaborating with the China Manned Space program for microbial breeding and maintaining strategic partnerships with medical institutions like Fudan University and Huashan Hospital. The company operates a portfolio of successful brands including CHANDO, MAYSU, and Biorrier, positioning itself at the intersection of consumer health and dermatological innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHANDO.